Mark Geißler

Mark Geißler has extensive work experience in the pharmaceutical industry, with a career spanning over two decades. Currently, they serve as a Member of the Supervisory Board at Aptissen SA since June 2021. Prior to that, they were the Head of Account Management at Aimmune Therapeutics from October 2020. Mark held the position of General Manager Germany at Fidia Pharma GmbH from September 2013 to October 2020, where their role involved creating a successful country organization. From October 2012 to August 2013, Mark Geißler served as the Managing Director at Molteni Pharma Deutschland GmbH. Before that, they were the Country Manager Germany at Molteni Farmaceutici from January 2011 to October 2012. Mark Geißler's career started in 2000 at Schwarz Pharma Deutschland GmbH, where they worked as a Pharmaceutical Representative until February 2005. Later, they joined Novartis Pharma GmbH, where they held the positions of Medical Relation Manager Allergy from March 2005 to April 2008 and Sales Manager Asthma and Allergy from May 2008 to December 2010.

Mark Geißler's education history includes two major institutions. From 1997 to 2000, they attended the University of Mainz and studied medicine. Following that, from 2001 to 2005, they enrolled at FernUniversität in Hagen and obtained a certificate in Marketing and Strategic Planning within the field of study of Business Administration. Additionally, Mark obtained several certifications, including "Coaching für mehr Wachstum" and "Coaching-Skills für Führungskräfte" from LinkedIn in February 2023, as well as "Excel: Pivot-Tabellen für Einsteiger" from LinkedIn in September 2022.